222555-05-7

Basic information

• Product Name: ethyl (2R)-2-ethoxy-3-(4-hydroxyphenyl)propanoate
• Synonyms: ethyl (2R)-2-ethoxy-3-(4-hydroxyphenyl)propanoate
• CAS NO: 222555-05-7
• Molecular Weight: 238.284
• Mol File: 222555-05-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: ethyl (2R)-2-ethoxy-3-(4-hydroxyphenyl)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (2R)-2-ethoxy-3-(4-hydroxyphenyl)propanoate(222555-05-7)
• EPA Substance Registry System: ethyl (2R)-2-ethoxy-3-(4-hydroxyphenyl)propanoate(222555-05-7)

Safety Data

• Hazardous Substances Data: 222555-05-7(Hazardous Substances Data)

Upstream product

• 482656-47-3 ethyl (2R)-3-[4-(benzyloxy)phenyl]-2-hydroxypropanoate 
• 222835-03-2 3-(4-benzyloxy-phenyl)-2-ethoxy-acrylic acid ethyl ester 
• 13676-06-7 ethyl 2-ethoxy-2-(diethylphosphono)acetate 
• 34006-60-5 ethyl 2-chloro-2-ethoxyacetate 
• 6065-82-3 Ethyl diethoxyacetate 
• 197299-16-4 ethyl 2-ethoxy-3-(4-hydroxy-phenyl)-propionate 
• 373368-68-4 (R)-3-[4-(benzyloxy)phenyl]-2-hydroxypropanoic acid 
• 847268-21-7 ethyl (2R)-3-[4-(benzyloxy)phenyl]-2-ethoxypropanoate 

Downstream Products

• 1022149-28-5 C₃₃H₃₉NO₅ 
• 305827-41-2 (-)-ethyl 2-ethoxy-3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]propanoate 
• 1416820-83-1 ethyl (2R)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl}propanoate 
• 1416820-84-2 (2R)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl}propanoic acid 
• 1416820-93-3 (R)-ethyl 2-ethoxy-3-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)phenyl)propanoate 
• 1416820-94-4 (R)-2-ethoxy-3-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)phenyl)propanoic acid 
• 305827-61-6 (-)-ethyl 2-ethoxy-3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]propanoate 

Relevant articles and documents

PPAR-SPARING COMPOUNDS FOR THE TREATMENT OF METABOLIC DISEASES

The present invention relates to hydroxamate compounds and pharmaceutical compositions that are useful for treating and/or preventing metabolic inflammation mediated diseases such as diabetes, obesity, hypertension, dyslipidemia, a neurodegenerative disorder (e.g., Alzheimer's disease, Parkinson's disease, or Huntington's disease), or any combination thereof. Moreover, the present invention also provides methods of treatment for these diseases or disorders.

PPAR-SPARING COMPOUNDS FOR USE IN THE TREATMENT OF DIABETES AND OTHER METABOLIC DISEASES

The present invention relates to compounds and pharmaceutical compositions that are useful for treating and/or preventing diabetes or other metabolic diseases, optionally in combination with a second therapy such an active pharmaceutical agent or diet restriction or an increase in duration or exertion in physical activity.

PROCESS FOR PREPARING 3-ARYL-2-HYDROXY PROPANOIC ACID DERIVATIVES WITHOUT RESOLUTION

The present invention discloses an improve process for the preparation of S (-) and R (+) 3-aryl-2-hydroxy propanoic acid derivatives without any resolution involved.